Home > Healthcare > Pharmaceuticals > Finished Drug Form > Oxytocin Market

Oxytocin Market Share

Report ID: GMI9261
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Oxytocin Market Share

The market exhibits a competitive landscape characterized by the presence of several key players striving for market dominance. Leading global players in the market, leverage their extensive product portfolios and robust distribution networks to maintain their market positions. Additionally, there is a notable presence of regional players and emerging biopharmaceutical companies focusing on oxytocin formulations, contributing to market competitiveness.

Key strategies adopted by market players include new product launches, strategic collaborations, mergers and acquisitions, and geographic expansions to strengthen their market foothold and gain a competitive edge. Moreover, ongoing R&D activities aimed at exploring novel therapeutic applications of oxytocin further intensify competition in the global market landscape.

Oxytocin Market Companies

Some of the eminent market participants operating in the oxytocin industry include:

Endo International plc
Ferring Pharmaceuticals
Fresenius SE & Co. KGaA
Hikma Pharmaceuticals PLC
Novartis AG
Pfizer Inc.
Sun Pharma Industries Limited.
Teva Pharmaceutical Industries Ltd.
Viatris Inc.
Wockhardt Limited
Yuhan Corporation

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oxytocin market size was USD 85.3 million in 2023 and is expected to register 9.5% CAGR from 2024-2032 owing to increasing incidence of pregnancy complications along with increase in childbirth rates, and growing awareness of induced labor and breastfeeding worldwide.

Oxytocin industry from the postpartum segment is expected to reach USD 135.4 million by 2032 due to its potential anti-inflammatory properties akin to those found in anti-inflammatory drugs, facilitating postpartum healing and recovery.

The U.S. oxytocin industry is expected to register 9.2% CAGR from 2024-2032 due to rise in childbirth rates and considerable demand for products and services related to childbirth and maternal health in the country.

Ferring Pharmaceuticals, Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Novartis AG, Pfizer Inc., Sun Pharma Industries Limited., Teva Pharmaceutical Industries Ltd., Viatris Inc., Wockhardt Limited, and Yuhan Corporation, are some of the major oxytocin companies worldwide.